Background/Objectives: Neisseria meningitidis is a human-specific pathogen capable of causing life-threatening illnesses. Occasionally, it is recovered from unusual sites, other than the bloodstream or the central nervous system. Herein, we describe two rare manifestations due to N. meningitidis within a year (2024) in Greece. Methods: Atypical infection due to N. meningitidis was diagnosed in two different patients: Case-1 presented with an inflammatory swelling in the mid-line of the neck, and Case-2 presented with swelling of the left knee. Both patients had high fever and no neurological signs at admission; Case-2 progressed to meningoencephalitis. Phenotypic and genotypic identifications were carried out in both cases. Results: Case-1 and Case-2 isolates were identified as follows: MenX: 18, 25-44, F5-5, ST-823; 198cc and MenB: 7-1, 1, F3-3, ST-7460; 32cc for PorA, FetA and MLST, respectively. MenX was identified for the first time in Greece and finetyping revealed rare genotypic characteristics. Both isolates were susceptible to cefotaxime, ceftriaxone and rifampicin, while Case-2 isolate expressed reduced susceptibility to penicillin and resistance to ciprofloxacin. Both patients recovered fully. Conclusions: Although uncommon, N. meningitidis may be isolated from atypical sites and specimens. Clinicians and microbiologists should remain aware that meningococcus is a potential cause of infections beyond meningitis and septicaemia.

Campylobacter jejuni and Campylobacter coli are the two main campylobacter species that cause foodborne campylobacteriosis. Recent studies have reported that Campylobacter spp. are prone to developing resistance to antibiotics commonly used for their treatment, with many C. coli strains identified as multidrug-resistant. This study presents the results of the whole-genome sequencing analysis of the multidrug-resistant C. coli strain BCT3 isolated in Greece from a stool specimen of a pediatric patient presenting with diarrhea. The strain was isolated using selective culture media and, based on antimicrobial susceptibility tests, was found to be resistant to ciprofloxacin, tetracycline, erythromycin, azithromycin, clarithromycin, and doxycycline. To further characterize it, we performed whole-genome sequencing, which identified strain BCT3 as C. coli. Moreover, multilocus sequence typing assigned the BCT3 to the sequence type (ST) 872, belonging to clonal complex ST-828. The presence of multiple virulence genes revealed its pathogenic potential. The detection of antimicrobial resistance genes and mutated alleles was indicative of its resistance to fluoroquinolones, macrolides, and tetracyclines, supporting the observed phenotype. To our knowledge, this is the first reported clinical case of such a multidrug-resistant C. coli strain in Greece.